Ignite Creation Date:
2024-05-05 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00116012
Status:
COMPLETED
Last Update Posted:
2006-11-29
First Post:
2005-06-26
Brief Title:
Anticoagulation With rNAPc2 to Eliminate MACETIMI 32
Sponsor:
ARCA Biopharma Inc
Organization:
ARCA Biopharma Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Coronary Disease |
Keywords:
| Name | View |
|---|---|
| thrombosis | View |
| acute coronary syndrome | View |
| rNAPc2 | View |
| unstable angina | View |
| Non-STE myocardial infarction | View |
| ST elevation | View |
| cardiac enzymes | View |
| acute coronary syndromes | View |
| factor VIIa | View |
| tissue factor | View |
| nematode anticoagulant protein c2 | View |
| anticoagulants | View |
| thrombin inhibitors | View |